Get API access

CRISPR Therapeutics reports narrower Q1 2026 loss

2 statements on Sep 23, 2026 12:22 UTC
Part of CRISPR Therapeutics funding expansion
News
Created
Updated
CRSP
All topics

Statements (2)

  1. Bullish

    One Wall Street analyst expects 85% gains for CRISPR Therapeutics

    247wallst.comHigh importance
  2. Bearish

    CRISPR Therapeutics stock is down 12 months

    247wallst.com

FinTopic

AI-powered financial news intelligence platform with interactive visualizations

Features

  • Interactive Treemap View
  • Real-time Sentiment Analysis
  • Multi-source Aggregation
  • Advanced Filtering

Product

Data

  • Real-time updates (within minutes)
  • Live sentiment analysis
  • Multi-source aggregation

© FinTopic. Market intelligence for modern traders.